Combining oncolytic adenovirus with radiation – a paradigm for the future of radiosensitization by O'Cathail, S, Pokrovska, TD, Maughan, TS, Fisher, KD, Seymour, LW, Hawkins, MA

Associations between cardiac irradiation and survival in patients with non-small cell lung cancer: Validation and new discoveries in an independent dataset by Vivekanandan, S, Fenwick, JD, Counsell, N, Panakis, N, Stuart, R, Higgins, G, Hawkins, MA

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer by Holyoake, DLP, Warren, DR, Hurt, C, Aznar, M, Partridge, M, Mukherjee, S, Hawkins, MA

Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC by Vivekanandan, S, Landau, DB, Counsell, N, Warren, DR, Farrelly, L, Ngai, Y, Hawkins, MA, Fenwick, JD

A prospective study of diffusion-weighted magnetic resonance imaging as an early prognostic biomarker in chemoradiotherapy in squamous cell carcinomas of the anus by Muirhead, R, Bulte, D, Cooke, R, Chu, K-Y, Durrant, L, Goh, V, Jacobs, C, Ng, SM, Strauss, VY, Virdee, PS, Qi, C, Hawkins, MA

Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma by Bluemke, E, Bulte, D, Bertrand, A, George, B, Cooke, R, Chu, K-Y, Durrant, L, Goh, V, Jacobs, C, Ng, SM, Strauss, VY, Hawkins, MA, Muirhead, R

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCAL... by Mukherjee, S, Qi, C, Shaw, R, Jones, CM, Bridgewater, JA, Radhakrishna, G, Patel, N, Holmes, J, Virdee, PS, Tranter, B, Parsons, P, Falk, S, Wasan, HS, Ajithkumar, TV, Holyoake, D, Roy, R, Scott-Brown, M, Hurt, CN, O'Neill, E, Sebag-Montefiore, D, Maughan, TS, Hawkins, MA, Corrie, P